Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer

Abstract

Loss of muscle mass is an independent predictor of postoperative early recurrence in pathological N2-positive NSCLC patients.